down arrow

Nanjing Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: CNE000000KV1
  • SHG: 600713
CNY
5.02
-0.06 (-1.18%)

Sep 22

SHG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Nanjing Pharmaceutical Co., Ltd.

Why is Nanjing Pharmaceutical Co., Ltd. ?

1
Poor Management Efficiency with a low ROCE of 9.08%
  • The company has been able to generate a Return on Capital Employed (avg) of 9.08% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
  • Poor long term growth as Net Sales has grown by an annual rate of 5.33% and Operating profit at 3.39% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 11.37% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 5.33% and Operating profit at 3.39% over the last 5 years
4
Flat results in Jun 26
  • OPERATING CASH FLOW(Y) Lowest at CNY -1,030.84 MM
  • INTEREST(Q) At CNY 75.05 MM has Grown at 15.79%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 2.56 times
5
With ROE of 11.34%, it has a very expensive valuation with a 0.90 Price to Book Value
  • Over the past year, while the stock has generated a return of 2.21%, its profits have risen by 9.6%
  • At the current price, the company has a high dividend yield of 3.4
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Nanjing Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Retailing should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Nanjing Pharmaceutical Co., Ltd. for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Nanjing Pharmaceutical Co., Ltd.
1.41%
0.38
30.57%
China Shanghai Composite
3.23%
0.23
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.33%
EBIT Growth (5y)
3.39%
EBIT to Interest (avg)
4.17
Debt to EBITDA (avg)
5.73
Net Debt to Equity (avg)
1.40
Sales to Capital Employed (avg)
2.85
Tax Ratio
28.67%
Dividend Payout Ratio
35.42%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.85%
ROE (avg)
11.37%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.90
EV to EBIT
13.05
EV to EBITDA
11.15
EV to Capital Employed
0.96
EV to Sales
0.31
PEG Ratio
NA
Dividend Yield
3.36%
ROCE (Latest)
7.35%
ROE (Latest)
11.34%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
DIVIDEND PAYOUT RATIO(Y)

Highest at 96.77%

RAW MATERIAL COST(Y)

Fallen by 1.82% (YoY

CASH AND EQV(HY)

Highest at CNY 5,309.89 MM

DIVIDEND PER SHARE(HY)

Highest at CNY 2.56

NET SALES(Q)

Highest at CNY 13,978.8 MM

-8What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY -1,030.84 MM

INTEREST(Q)

At CNY 75.05 MM has Grown at 15.79%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.56 times

Here's what is working for Nanjing Pharmaceutical Co., Ltd.

Net Sales
Highest at CNY 13,978.8 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Cash and Eqv
Highest at CNY 5,309.89 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Dividend per share
Highest at CNY 2.56
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (CNY)

Dividend Payout Ratio
Highest at 96.77%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost
Fallen by 1.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nanjing Pharmaceutical Co., Ltd.

Operating Cash Flow
Lowest at CNY -1,030.84 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest
At CNY 75.05 MM has Grown at 15.79%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debtors Turnover Ratio
Lowest at 2.56 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Footer loading